Sign Up Today and Learn More About Enliven Therapeutics Stock
Invest in or calculate the value of your shares in Enliven Therapeutics or other pre-IPO companies through EquityZen's platform.
Enliven Therapeutics Stock
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
About Enliven Therapeutics Stock
Founded
2019
Headquarters
Boulder, CO, US
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. The company's discovery process combines clinically validated biological targets and industry-leading chemistry to address the limitations of existing therapies. This approach allows us to efficiently and effectively develop precision oncology therapeutics that enhance overall patient well-being. Founded in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is based in Boulder, Colorado.
Enliven Therapeutics Press Mentions
Stay in the know about the latest news on Enliven Therapeutics
Enliven Therapeutics announces $90M private placement to fund R&D activities
seekingalpha • Mar 19, 2024
Expenses grow as Enliven Therapeutics drug trials ramp up
bizwest • Mar 16, 2024
Enliven Therapeutics GAAP EPS of -$0.51
seekingalpha • Nov 10, 2023
Enliven Therapeutics 10% owner disposes of ~$3M worth of shares
seekingalpha • Sep 29, 2023
Enliven Therapeutics divulges new HER2 inhibitors for cancer
bioworld • Sep 07, 2023
Enliven Therapeutics Management
Leadership team at Enliven Therapeutics
Co-Founder and CEO
Sam Kintz
Co-founder and Chief Operating Officer
Anish Patel
Join now and verify your accreditation status to gain access to:
- Enliven Therapeutics Current Valuation
- Enliven Therapeutics Stock Price
- Enliven Therapeutics Management
- Available deals in Enliven Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Enliven Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Enliven Therapeutics Revenue and Financials
- Enliven Therapeutics Highlights
- Enliven Therapeutics Business Model
- Enliven Therapeutics Risk Factors
- Enliven Therapeutics Research Report from SACRA Research
Trading Enliven Therapeutics Stock
How to invest in Enliven Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Enliven Therapeutics through EquityZen funds. These investments are made available by existing Enliven Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Enliven Therapeutics stock?
Shareholders can sell their Enliven Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."